Article info
PDFTherapeutics
Systematic review
Low-quality evidence that atovaquone-proguanil and doxycycline are better tolerated prophylactic antimalarial regimens in travellers than mefloquine
- Michael Hawkes
Institute of Medical Sciences, University of Toronto, 10-401, 101 College Street, Toronto, Ontario, Canada M5G 1L7; Michael.hawkes{at}utoronto.ca
Citation
Low-quality evidence that atovaquone-proguanil and doxycycline are better tolerated prophylactic antimalarial regimens in travellers than mefloquine
Publication history
- First published February 23, 2010.
Online issue publication
August 31, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions